Active substances

Abacavir›

J05AF06 Antiinfectives for systemic use | Direct acting antivirals | Nucleoside and nucleotide reverse transcriptase inhibitors

Indicated for: HIV-1 infection

Abacavir + lamivudine›

J05AR02 Antiinfectives for systemic use | Direct acting antivirals | Antivirals for treatment of HIV infections, combinations

Indicated for: HIV-1 infection

Abacavir + lamivudine + zidovudine›

J05AR04 Antiinfectives for systemic use | Direct acting antivirals | Antivirals for treatment of HIV infections, combinations

Indicated for: HIV-1 infection

Abatacept›

L04AA24 Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Selective immunosuppressants

Indicated for: rheumatoid arthritis

Abciximab›

B01AC13 Blood and blood forming organs | Antithrombotic agents | Antithrombotic agents | Platelet aggregation inhibitors excl. heparin

Indicated for: prevention of thrombotic complications in coronary interventions

Abemaciclib›

L01EF03 Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Cyclin-dependent kinase (CDK) inhibitors

Indicated for: breast cancer

Abiraterone›

L02BX03 Antineoplastic and immunomodulating agents | Hormone antagonists and related agents | Other hormone antagonists and related agents

Indicated for: prostate cancer

Abrocitinib›

D11AH08 Dermatologicals | Other dermatological preparations | Other dermatological preparations | Agents for dermatitis, excluding corticosteroids

Indicated for: atopic dermatitis

Acalabrutinib›

L01EL02 Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Bruton's tyrosine kinase (BTK) inhibitors

Indicated for: hematologic malignancies

Acarbose›

A10BF01 Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Alpha glucosidase inhibitors

Indicated for: type 2 diabetes mellitus

Aceclofenac›

M01AB16 Musculo-skeletal system | Antiinflammatory and antirheumatic products | Antiinflammatory and antirheumatic products, non-steroids | Acetic acid derivatives and related substances

Indicated for: pain and inflammation

Acemetacin›

M01AB11 Musculo-skeletal system | Antiinflammatory and antirheumatic products | Antiinflammatory and antirheumatic products, non-steroids | Acetic acid derivatives and related substances

Indicated for: pain and inflammation

Acenocoumarol›

B01AA07 Blood and blood forming organs | Antithrombotic agents | Antithrombotic agents | Vitamin K antagonists

Indicated for: prevention and treatment of thromboembolism

Acetazolamide›

S01EC01 Sensory organs | Antiglaucoma preparations and miotics | Carbonic anhydrase inhibitors

Indicated for: glaucoma; edema; epilepsy

Acetylcholine chloride›

S01EB09 Sensory organs | Antiglaucoma preparations and miotics | Parasympathomimetics

Indicated for: miosis during ocular surgery

Acetylcysteine›

R05CB01 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics

Indicated for: viscous bronchial secretions; paracetamol overdose

Acetylcysteine + tuaminoheptane sulfate›

R01AB08 Respiratory system | Decongestants and other nasal preparations for topical use | Sympathomimetics, combinations excl. corticosteroids

Indicated for: productive cough; expectoration

Acetylsalicylic acid›

B01AC06 Blood and blood forming organs | Antithrombotic agents | Antithrombotic agents | Platelet aggregation inhibitors excl. heparin

Indicated for: pain; fever

Acetylsalicylic acid + ascorbic acid›

N02BA51 Nervous system | Other analgesics and antipyretics | Salicylic acid and derivatives

Indicated for: cold and flu symptoms

Acetylsalicylic acid + atorvastatin + ramipril›

C10BX06 Cardiovascular system | Lipid modifying agents | Lipid modifying agents, combinations | Lipid modifying agents in combination with other drugs

Indicated for: cardiovascular prevention

Acetylsalicylic acid + bisoprolol›

C07AB57 Cardiovascular system | Beta blocking agents | Beta blocking agents | Beta blocking agents, selective

Indicated for: cardiovascular prevention

Acetylsalicylic acid + caffeine›

N02BA51 Nervous system | Other analgesics and antipyretics | Salicylic acid and derivatives

Indicated for: cold and flu symptoms

Acetylsalicylic acid + dipyridamole›

B01AC30 Blood and blood forming organs | Antithrombotic agents | Antithrombotic agents | Platelet aggregation inhibitors excl. heparin

Indicated for: cardiovascular prevention

Acetylsalicylic acid + esomeprazole›

B01AC56 Blood and blood forming organs | Antithrombotic agents | Antithrombotic agents | Platelet aggregation inhibitors excl. heparin

Indicated for: pain; fever

Acetylsalicylic acid + paracetamol + caffeine›

N02BA51 Nervous system | Other analgesics and antipyretics | Salicylic acid and derivatives

Indicated for: cold and flu symptoms

Acetylsalicylic acid + paracetamol + caffeine + chlorpheniramine maleate›

N02BA51 Nervous system | Other analgesics and antipyretics | Salicylic acid and derivatives

Indicated for: cold and flu symptoms

Acetylsalicylic acid + paracetamol + caffeine + codeine›

N02BA51 Nervous system | Other analgesics and antipyretics | Salicylic acid and derivatives

Indicated for: cold and flu symptoms

Acetylsalicylic acid + paracetamol + caffeine + codeine + phenobarbital›

N02BA71 Nervous system | Other analgesics and antipyretics | Salicylic acid and derivatives

Indicated for: cold and flu symptoms

Acetylsalicylic acid + paracetamol + codeine›

N02BA51 Nervous system | Other analgesics and antipyretics | Salicylic acid and derivatives

Indicated for: pain; fever

Acetylsalicylic acid + paracetamol + phenobarbital + caffeine + codeine›

N02BA71 Nervous system | Other analgesics and antipyretics | Salicylic acid and derivatives

Indicated for: cold and flu symptoms